Contribute Try STAT+ Today

STAT Plus subscribers, we want to know what you think.

The last time we polled you, the new tax law was wending its way through Congress, Tom Price still had a seat in the Trump cabinet, and PhRMA was launching its “Go Boldly” campaign on the heels of a hike in membership fees.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Let me just say that unless something is done regarding PBM’s there will not be
    one Independent pharmacy left in this country. If that were to happen . Shame on this government !!!!!!

Comments are closed.